Masimo Co. (NASDAQ:MASI) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System cut its stake in shares of Masimo Co. (NASDAQ:MASI) by 7.3% during the third quarter, Holdings Channel.com reports. The institutional investor owned 45,448 shares of the medical equipment provider’s stock after selling 3,600 shares during the quarter. New York State Teachers Retirement System’s holdings in Masimo were worth $6,060,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of MASI. NBC Securities Inc. raised its holdings in shares of Masimo by 47.1% during the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 73 shares during the last quarter. GAMMA Investing LLC grew its position in Masimo by 75.0% during the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 111 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in Masimo by 133.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 200 shares during the period. HHM Wealth Advisors LLC raised its stake in shares of Masimo by 25.0% during the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock valued at $79,000 after buying an additional 125 shares during the last quarter. Finally, Lazard Asset Management LLC lifted its holdings in shares of Masimo by 5,730.0% in the 1st quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 573 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Trading Up 2.8 %

Shares of NASDAQ:MASI opened at $151.56 on Wednesday. The firm has a market capitalization of $8.06 billion, a price-to-earnings ratio of 103.10 and a beta of 0.97. The business’s 50 day moving average price is $130.72 and its 200-day moving average price is $125.34. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. Masimo Co. has a 1 year low of $75.36 and a 1 year high of $153.93.

Masimo (NASDAQ:MASI) last announced its earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business had revenue of $496.30 million for the quarter, compared to analyst estimates of $493.92 million. During the same quarter last year, the business earned $0.62 earnings per share. The company’s revenue for the quarter was up 9.0% compared to the same quarter last year. On average, equities research analysts forecast that Masimo Co. will post 3.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on MASI shares. Piper Sandler reaffirmed an “overweight” rating on shares of Masimo in a report on Friday, October 18th. BTIG Research lifted their target price on shares of Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a report on Monday, October 14th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $145.33.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.